ES2086413T3 - Utilizacion de agentes antigestagenos para la preparacion de medicamentos. - Google Patents

Utilizacion de agentes antigestagenos para la preparacion de medicamentos.

Info

Publication number
ES2086413T3
ES2086413T3 ES90914901T ES90914901T ES2086413T3 ES 2086413 T3 ES2086413 T3 ES 2086413T3 ES 90914901 T ES90914901 T ES 90914901T ES 90914901 T ES90914901 T ES 90914901T ES 2086413 T3 ES2086413 T3 ES 2086413T3
Authority
ES
Spain
Prior art keywords
antigestagen
medicines
agents
preparation
antigestagens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90914901T
Other languages
English (en)
Inventor
Horst Michna
Martin Schneider
Etreby M Fathy El
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Application granted granted Critical
Publication of ES2086413T3 publication Critical patent/ES2086413T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LOS ANTIGESTAGENOS (ANTAGONISTAS DE PROGESTERONA COMPETITIVOS) SON ADECUADOS PARA LA PRODUCCION DE MEDICAMENTOS PARA TRATAR LOS CANCERES DE MAMA CON UN MAYOR CONTENIDO DE CELULAS TUMORALES EN LA FASE S DEL CICLO CELULAR, CONSIDERADO COMO DE ALTO RIESGO.
ES90914901T 1989-10-11 1990-10-11 Utilizacion de agentes antigestagenos para la preparacion de medicamentos. Expired - Lifetime ES2086413T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3934405A DE3934405A1 (de) 1989-10-11 1989-10-11 Verwendung von antigestagenen zur herstellung von arzneimitteln

Publications (1)

Publication Number Publication Date
ES2086413T3 true ES2086413T3 (es) 1996-07-01

Family

ID=6391518

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90914901T Expired - Lifetime ES2086413T3 (es) 1989-10-11 1990-10-11 Utilizacion de agentes antigestagenos para la preparacion de medicamentos.

Country Status (10)

Country Link
EP (1) EP0495825B1 (es)
JP (1) JPH05500947A (es)
AT (1) ATE135219T1 (es)
AU (1) AU648046B2 (es)
CA (1) CA2067173A1 (es)
DE (2) DE3934405A1 (es)
DK (1) DK0495825T3 (es)
ES (1) ES2086413T3 (es)
GR (1) GR3019824T3 (es)
WO (1) WO1991005557A1 (es)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0310542B1 (de) * 1987-10-01 1994-06-08 Schering Aktiengesellschaft Antigestagen- und antiöstrogenwirksame Verbindungen zur Behandlung hormonabhängiger Tumoren

Also Published As

Publication number Publication date
DE59010204D1 (de) 1996-04-18
ATE135219T1 (de) 1996-03-15
JPH05500947A (ja) 1993-02-25
CA2067173A1 (en) 1991-04-12
GR3019824T3 (en) 1996-08-31
AU6524590A (en) 1991-05-16
EP0495825B1 (de) 1996-03-13
AU648046B2 (en) 1994-04-14
DK0495825T3 (da) 1996-07-22
DE3934405A1 (de) 1991-04-18
WO1991005557A1 (de) 1991-05-02
EP0495825A1 (de) 1992-07-29

Similar Documents

Publication Publication Date Title
ES2069750T3 (es) Metodos y composiciones para curar huesos.
ES2147720T3 (es) Factor de celulas madre.
BR9814857A (pt) Processos para tratar leucemia, câncer sólido eleucemia, linfoma ou tumores sólidos em umhumano, e para fabricar uma composiçãofarmacêutica estéril, e, a respectiva composiçãofarmacêutica estéril
ES2037083T3 (es) Gen de eritropoietina: expresion de alto nivel en celulas de mamiferos transfectadas de forma estable.
ES2074867T3 (es) Derivados de quinazolina para potenciar la actividad antitumoral.
GT197956109A (es) Pyri dinyl-2(ih)-pyridinones y su preparacion
ES2190472T3 (es) Parche transdermico para la administracion de 17-deacetil norgestimato, solo o en combinacion con un estrogeno.
ES2003863B3 (es) Nueva preparacion farmaceutica con liberacion controlada de metoprolol, metodo para su fabricacion y uso de la nueva preparacion.
BR0113235A (pt) Composições e métodos para a terapia e a diagnose de malignidades associadas com her-2/neu
CA2221753A1 (en) Use of flavanolignanes for the preparation of medicaments with antiproliferative activity in uterus, ovary and breast
IT1205849B (it) Derivati di indolo,procedimenti per prepararli e composizioni farmaceutiche che li contengono per il trattamento di emicrania
IT8848730A0 (it) Derivati 17beta-oh 19-nor steroidei sostituiti in 17alfa, procedimento di preparazione, loro impiego come medicamenti e composizioni farmaceutiche che li compongono
ES2108129T3 (es) Nuevos derivados de pirazina, su preparacion y empleo.
EP0137542A3 (en) Pharmaceutical composition for the treatment of states of acute renal insufficiency
BR9608488A (pt) Uso de derivados da vitamina d4 no tratamento de câncer
ES2099075T3 (es) Conjugados de antraciclina con un nuevo engarce y procedimientos para su produccion.
ES2107414T3 (es) Utilizacion de interferon-beta humano para la estimulacion de la eritropoyesis.
IT1216772B (it) Derivati di indolo ,procedimento per prepararli e composizioni farmaceutiche che li contengono per il trattamento di emicrania
AU6788687A (en) A pharmaceutical which can be administered nasally, a process for its preparation, and its use
ES2086413T3 (es) Utilizacion de agentes antigestagenos para la preparacion de medicamentos.
DE2962580D1 (en) 7-phenyl-quinolizidine derivatives (i), their preparation, pharmaceutical compositions containing them and (i) for use in treating diseases
ES2126575T3 (es) Sacarosa-fosfato-sintasa (sps), su procedimiento de preparacion, su adnc, y utilizacion de adnc para modificar la expresion de sps en celulas vegetales.
ECSP034606A (es) Uso de antiprogestinas para la induccion de apoptosis en una celula
ES2052863T3 (es) Azolilmetilcarbinoles sustituidos por ciclopropilo, procedimiento para su preparacion y su uso como medicamento.
ATE334683T1 (de) Verwendung von 11beta-(4-acetylphenyl)-17beta-

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 495825

Country of ref document: ES